way 120491 has been researched along with zeneca zd 6169 in 3 studies
Studies (way 120491) | Trials (way 120491) | Recent Studies (post-2010) (way 120491) | Studies (zeneca zd 6169) | Trials (zeneca zd 6169) | Recent Studies (post-2010) (zeneca zd 6169) |
---|---|---|---|---|---|
11 | 0 | 0 | 42 | 0 | 3 |
Protein | Taxonomy | way 120491 (IC50) | zeneca zd 6169 (IC50) |
---|---|---|---|
ATP-binding cassette sub-family C member 9 | Homo sapiens (human) | 1.6 | |
ATP-binding cassette sub-family C member 8 | Homo sapiens (human) | 1.6 | |
ATP-sensitive inward rectifier potassium channel 11 | Homo sapiens (human) | 1.6 | |
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial | Homo sapiens (human) | 9.3 | |
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial | Homo sapiens (human) | 9.3 | |
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial | Homo sapiens (human) | 9.3 | |
ATP-sensitive inward rectifier potassium channel 8 | Homo sapiens (human) | 1.6 | |
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial | Homo sapiens (human) | 9.3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Antane, MM; Antane, SA; Argentieri, TM; Butera, JA; Freeden, C; Graceffa, RF; Hirth, BH; Jenkins, D; Lennox, JR; Matelan, E; Norton, NW; Quagliato, D; Sheldon, JH; Spinelli, W; Warga, D; Wojdan, A; Woods, M | 1 |
Antane, MM; Argentieri, TM; Butera, JA; Francisco, GD; Freeden, C; Gilbert, AM; Graceffa, RF; Gundersen, EG; Herbst, D; Hirth, BH; Lennox, JR; McFarlane, G; Norton, NW; Quagliato, D; Sheldon, JH; Warga, D; Wojdan, A; Woods, M | 1 |
Antane, MM; Antane, SA; Argentieri, TM; Butera, JA; Colatsky, TJ; Freeden, C; Norton, NW; Oshiro, G; Sheldon, JH; Spinelli, W; Warga, D; Wojdan, A; Woods, M | 1 |
3 other study(ies) available for way 120491 and zeneca zd 6169
Article | Year |
---|---|
Design and SAR of novel potassium channel openers targeted for urge urinary incontinence. 1. N-Cyanoguanidine bioisosteres possessing in vivo bladder selectivity.
Topics: Adenosine Triphosphate; Animals; Blood Pressure; Cyclobutanes; Drug Design; Drug Evaluation, Preclinical; Female; Heart Rate; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Nitriles; Patch-Clamp Techniques; Potassium Channels; Potassium Chloride; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Urinary Bladder; Urinary Incontinence | 2000 |
Design and SAR of novel potassium channel openers targeted for urge urinary incontinence. 2. Selective and potent benzylamino cyclobutenediones.
Topics: Adenosine Triphosphate; Animals; Benzylamines; Blood Pressure; Cyclobutanes; Drug Design; Drug Evaluation, Preclinical; Female; Heart Rate; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Potassium Channels; Potassium Chloride; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Urinary Bladder; Urinary Incontinence | 2000 |
Comparison of the potassium channel openers, WAY-133537, ZD6169, and celikalim on isolated bladder tissue and In vivo bladder instability in rat.
Topics: Amides; Animals; Benzophenones; Benzopyrans; Blood Pressure; Cyclobutanes; Dose-Response Relationship, Drug; Female; Heart Rate; Hemodynamics; Hypertrophy; In Vitro Techniques; Indoles; Male; Membrane Potentials; Molecular Structure; Muscle Contraction; Muscle, Smooth; Nitriles; Patch-Clamp Techniques; Potassium Channels; Rats; Rats, Sprague-Dawley; Urinary Bladder | 1999 |